28.09.2016
- As CEO Ian Read hinted earlier, Pfizer has officially ditched plans to break into two separate publicly traded companies dedicated to mature or off-patent products and new...
22.08.2016
- Pfizer has won the race for biotech firm Medivation. The US drugs giant has agreed to pay about $14 billion in a move that adds leading prostate cancer drug Xtandi to its portfolio...
19.08.2016
- US-based Merck & Co is the latest company to consider buying US biopharmaceuticals firm Medivation. Citing people familiar with the matter, news agency Reuters reported that Merck...
07.07.2016
- Under months of pressure from Sanofi as an acquisition target, Medivation has now agreed to allow the French drugmaker to look at its books. Sanofi announced on Jul. 5 it had...
15.06.2016
- French drugmaker Sanofi today said it has filed definitive consent solicitation materials with the US Securities and Exchange Commission (SEC) seeking to remove and replace the...
09.06.2016
- French drugmaker Sanofi, which is pursuing a takeover of US biopharmaceuticals producer Medivation, has filed an investor presentation with the US Securities and Exchange...
09.05.2016
- Sanofi is turning up the heat on its acquisition target, US biopharmaceuticals producer Medivation, but the strategy doesn’t seem to be working. Last week, the French drugmaker...
02.05.2016
- The board of US biopharmaceuticals producer Medivation has unanimously rejected French drugmaker Sanofi’s $9.3 billion bid to acquire the company. David Hung, founder, president...
